Liu Yangyang, Liu Zhuoqiong, Wu Nan
Developmental Behavior Pediatrics, The Sixth Affiliated Hospital of Harbin Medical University, Harbin, China.
Child Health Section, The Sixth Affiliated Hospital of Harbin Medical University, Harbin, China.
Front Nutr. 2024 Jul 17;11:1430140. doi: 10.3389/fnut.2024.1430140. eCollection 2024.
The prevalence of obesity (Ob), overweight (Ow) and central obesity (CO) in children and adolescents has increased dramatically over the past decades globally. Flavanones have been recently studied as adjuvants for the treatment of obesity. This study was aimed at evaluating the association between intake of flavanones and its subclasses and the Ow/Ob and CO in children and adolescents.
This cross-sectional study extracted the data of children and adolescents with Ow/Ob and CO from the National Health and Nutrition Examination Survey (NHANES) database for 2007-2010 and 2017-2018. Ow and Ob were defined as a body mass index (BMI) ≥ 85 percentile. CO was defined as a waist circumference (WC) ≥ 90th percentile. The association between intake of flavanones and its subclasses and the Ow/Ob and CO in children and adolescents was determined by weighted univariate and multivariate Logistic regression models adjusted for potential covariates, and odds ratios (ORs) with 95% confidence intervals (CIs) was calculated. To further explore association between intake of flavanones and its subclasses and the Ow/Ob and CO in children and adolescents, subgroup analyses stratified by age, and gender.
Of the total 5,970 children and adolescents, 2,463 (41.2%) developed Ow/Ob and 1,294 (21.7%) patients developed CO. High intake of flavanones, eriodictyol, hesperetin, and naringenin were associated with lower odds of Ow/Ob in children and adolescents. (OR: 0.75, 95%CI: 0.62-0.92, OR: 0.69, 95%CI: 0.55-0.87, OR: 0.69, 95%CI: 0.55-0.87, and OR: 0.76, 95%CI: 0.63-0.92, respectively). In addition, high intake of flavanones, eriodictyol, and naringenin were associated with lower odds of CO in children and adolescents (OR: 0.71, 95%CI: 0.57-0.88, OR: 0.67, 95%CI: 0.51-0.86, and OR: 0.69, 95%CI: 0.55-0.86, respectively). Subgroup analyses showed that among all the different subgroups, high intake of flavanones was associated with lower odds of Ow/Ob and CO in children and adolescents.
A diet loaded with high flavanones were associated with lower odds of Ow/Ob and CO in children and adolescents, and children and adolescents should be encouraged to increase their intake of flavanones.
在过去几十年里,全球儿童和青少年肥胖(Ob)、超重(Ow)及中心性肥胖(CO)的患病率急剧上升。黄烷酮类化合物最近被作为肥胖治疗的辅助药物进行研究。本研究旨在评估黄烷酮类化合物及其亚类的摄入量与儿童和青少年的超重/肥胖及中心性肥胖之间的关联。
这项横断面研究从2007 - 2010年和2017 - 2018年的美国国家健康与营养检查调查(NHANES)数据库中提取了超重/肥胖及中心性肥胖儿童和青少年的数据。超重和肥胖定义为体重指数(BMI)≥第85百分位数。中心性肥胖定义为腰围(WC)≥第90百分位数。通过对潜在协变量进行调整的加权单变量和多变量逻辑回归模型,确定黄烷酮类化合物及其亚类的摄入量与儿童和青少年的超重/肥胖及中心性肥胖之间的关联,并计算95%置信区间(CI)的比值比(OR)。为进一步探讨黄烷酮类化合物及其亚类的摄入量与儿童和青少年的超重/肥胖及中心性肥胖之间的关联,按年龄和性别进行亚组分析。
在总共5970名儿童和青少年中,2463名(41.2%)出现超重/肥胖,1294名(21.7%)患者出现中心性肥胖。黄烷酮类化合物、圣草酚、橙皮素和柚皮素的高摄入量与儿童和青少年超重/肥胖的较低几率相关。(OR分别为:0.75,95%CI:0.62 - 0.92;OR:0.69,95%CI:0.55 - 0.87;OR:0.69,95%CI:0.55 - 0.87;OR:0.76,95%CI:0.63 - 0.92)。此外,黄烷酮类化合物、圣草酚和柚皮素的高摄入量与儿童和青少年中心性肥胖的较低几率相关(OR分别为:0.71,95%CI:0.57 - 0.88;OR:0.67,95%CI:0.51 - 0.86;OR:0.69,95%CI:0.55 - 0.86)。亚组分析表明,在所有不同亚组中,黄烷酮类化合物的高摄入量与儿童和青少年超重/肥胖及中心性肥胖的较低几率相关。
富含高黄烷酮类化合物的饮食与儿童和青少年超重/肥胖及中心性肥胖的较低几率相关,应鼓励儿童和青少年增加黄烷酮类化合物的摄入量。